Page last updated: 2024-08-24

vorozole and Carcinoma, Anaplastic

vorozole has been researched along with Carcinoma, Anaplastic in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bria, E; Carlini, P; Cognetti, F; Di Cosimo, S; Fabi, A; Felici, A; Ferretti, G; Giannarelli, D; Milella, M; Mottolese, M; Nisticò, C; Papaldo, P; Ruggeri, EM; Terzoli, E	1
Christov, K; Graves, J; Hu, L; Kelloff, G; Lubet, R; Mehta, RR; Shilkaitis, A; Steele, V; You, M	1
Bijnens, L; Michiels, B; Molenberghs, G; Thijs, H; Vangeneugden, T	1

Reviews

1 review(s) available for vorozole and Carcinoma, Anaplastic

Article	Year
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials. Cancer, 2005, Oct-01, Volume: 104, Issue:7 Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Probability; Prognosis; Remission Induction; Risk Assessment; Survival Analysis; Triazoles	2005

Article

Year

New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials.

Cancer, 2005, Oct-01, Volume: 104, Issue:7

Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Probability; Prognosis; Remission Induction; Risk Assessment; Survival Analysis; Triazoles

2005

Other Studies

2 other study(ies) available for vorozole and Carcinoma, Anaplastic

Article	Year
Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis. Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 2000, Volume: 11, Issue:8 Topics: Animals; Apoptosis; Aromatase Inhibitors; bcl-2-Associated X Protein; Carcinoma; Epithelial Cells; Female; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Animal; Precancerous Conditions; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; RNA, Messenger; Triazoles	2000
Selection models and pattern-mixture models to analyse longitudinal quality of life data subject to drop-out. Statistics in medicine, 2002, Apr-30, Volume: 21, Issue:8 Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Female; Humans; Longitudinal Studies; Models, Statistical; Neoplasms, Hormone-Dependent; Patient Dropouts; Quality of Life; Triazoles	2002

Article

Year

Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis.

Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 2000, Volume: 11, Issue:8

Topics: Animals; Apoptosis; Aromatase Inhibitors; bcl-2-Associated X Protein; Carcinoma; Epithelial Cells; Female; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Animal; Precancerous Conditions; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; RNA, Messenger; Triazoles

2000

Selection models and pattern-mixture models to analyse longitudinal quality of life data subject to drop-out.

Statistics in medicine, 2002, Apr-30, Volume: 21, Issue:8

Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Female; Humans; Longitudinal Studies; Models, Statistical; Neoplasms, Hormone-Dependent; Patient Dropouts; Quality of Life; Triazoles

2002